SCHEMBL4041724

SCHEMBL4041724

COC(CNc1nc2c(cc1-c1c(C)cccc1Cl)nc(N)c1cncn12)OC

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4042428 0.85 LCK (0.44) LCK
SCHEMBL4036109 0.84 LCK (0.46) LCK
SCHEMBL4041458 0.83 LCK (0.53) LCK
SCHEMBL4044486 0.83 LCK (0.38) LCK
SCHEMBL4037163 0.82 FGFR1 (0.43) LCK
SCHEMBL4041184 0.79 LCK (0.55) LCK
SCHEMBL4036362 0.79 LCK (0.41) LCK
SCHEMBL6626585 0.72 LCK (0.45) LCK
SCHEMBL4036111 0.69 LCK (0.42) LCK
SCHEMBL7983065 0.69 LCK (0.52) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1066286-B1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2009-04-29 EP claimed
EP-1066286-B1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2009-04-29 EP disclosed